• Users Online: 121
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Aberrant expression of p14ARF in human cancers: A new biomarker?

Inoue Kazushi, Fry Elizabeth A

Year : 2018| Volume: 1| Issue : 2 | Page no: 37-44

   This article has been cited by
1 Current understanding of epigenetics role in melanoma treatment and resistance
Mohsen Karami Fath, Ali Azargoonjahromi, Asma Soofi, Faezeh Almasi, Shahnaz Hosseinzadeh, Saeed Khalili, Kamran Sheikhi, Saeid Ferdousmakan, Soroor Owrangi, Minoovash Fahimi, Hamidreza Zalpoor, Mohsen Nabi Afjadi, Zahra Payandeh, Navid Pourzardosht
Cancer Cell International. 2022; 22(1)
[Pubmed]  [Google Scholar] [DOI]
2 The Cell Cycle-Associated Protein CDKN2A May Promotes Colorectal Cancer Cell Metastasis by Inducing Epithelial-Mesenchymal Transition
Wei-Kun Shi, Yun-Hao Li, Xue-Shan Bai, Guo-Le Lin
Frontiers in Oncology. 2022; 12
[Pubmed]  [Google Scholar] [DOI]
3 Dying to Survive—The p53 Paradox
Andrea Lees,Tamas Sessler,Simon McDade
Cancers. 2021; 13(13): 3257
[Pubmed]  [Google Scholar] [DOI]
4 P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment
Federica Pezzuto,Francesca Lunardi,Luca Vedovelli,Francesco Fortarezza,Loredana Urso,Federica Grosso,Giovanni Luca Ceresoli,Izidor Kern,Gregor Vlacic,Eleonora Faccioli,Marco Schiavon,Dario Gregori,Federico Rea,Giulia Pasello,Fiorella Calabrese
Frontiers in Oncology. 2021; 11
[Pubmed]  [Google Scholar] [DOI]
5 Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications
Daniel Desaulniers, Paule Vasseur, Abigail Jacobs, M. Cecilia Aguila, Norman Ertych, Miriam N. Jacobs
International Journal of Molecular Sciences. 2021; 22(20): 10969
[Pubmed]  [Google Scholar] [DOI]
6 Survival of Lung Cancer Patients Dependent on the LOH Status for DMP1, ARF, and p53
Elizabeth A. Fry,Gloria E. Niehans,Robert A. Kratzke,Fumitake Kai,Kazushi Inoue
International Journal of Molecular Sciences. 2020; 21(21): 7971
[Pubmed]  [Google Scholar] [DOI]
7 Different Camptothecin Sensitivities in Subpopulations of Colon Cancer Cells Correlate with Expression of Different Phospho-Isoforms of Topoisomerase I with Different Activities
Cinzia Tesauro,Josephine Geertsen Keller,Irina Gromova,Pavel Gromov,Rikke Frøhlich,Jens Uldum Erlandsen,Anni H. Andersen,Magnus Stougaard,Birgitta R. Knudsen
Cancers. 2020; 12(5): 1240
[Pubmed]  [Google Scholar] [DOI]
8 Increased Expression of NPM1 Suppresses p27Kip1 Function in Cancer Cells
Tatsuya Kometani,Takuya Arai,Taku Chibazakura
Cancers. 2020; 12(10): 2886
[Pubmed]  [Google Scholar] [DOI]
9 Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
Irene Vanni,Enrica Teresa Tanda,Bruna Dalmasso,Lorenza Pastorino,Virginia Andreotti,William Bruno,Andrea Boutros,Francesco Spagnolo,Paola Ghiorzo
Frontiers in Molecular Biosciences. 2020; 7
[Pubmed]  [Google Scholar] [DOI]
10 Jab1 promotes gastric cancer tumorigenesis via non-ubiquitin proteasomal degradation of p14ARF
Lin Wang,Wen-Qi Du,Min Xie,Man-Ru Liu,Fu-Chun Huo,Jing Yang,Dong-Sheng Pei
Gastric Cancer. 2020;
[Pubmed]  [Google Scholar] [DOI]
11 Interaction Proteomics Identifies ERbeta Association with Chromatin Repressive Complexes to Inhibit Cholesterol Biosynthesis and Exert An Oncosuppressive Role in Triple-negative Breast Cancer
Elena Alexandrova,Giorgio Giurato,Pasquale Saggese,Giovanni Pecoraro,Jessica Lamberti,Maria Ravo,Francesca Rizzo,Domenico Rocco,Roberta Tarallo,Tuula A. Nyman,Francesca Collina,Monica Cantile,Maurizio Di Bonito,Gerardo Botti,Giovanni Nassa,Alessandro Weisz
Molecular & Cellular Proteomics. 2020; 19(2): 245
[Pubmed]  [Google Scholar] [DOI]


Read this article